The International Dispensary Association Foundation (IDA Foundation) was created in 1972 in Amsterdam. [1] Its goal is to improve access to important medications and health care equipment in the developing world. [1] It works to achieve this by directly selling these items to organizations working in those areas of the world. [1] It is a not for profit organisation. [2] As of 2019 they were selling more than 3,000 products in more than 130 countries. [1] What they distribute is based in part on the WHO Model List of Essential Medicines. [1]
Oily chloramphenicol (or chloramphenicol oil suspension) is a long-acting preparation of chloramphenicol first introduced by Roussel Uclaf in 1954; marketed as Tifomycine, it was originally used as a treatment for typhoid. Roussel stopped production of oily chloramphenicol in 1995; the IDA Foundation has manufactured it since 1998, first in Malta and then in India from December 2004. [3]
- ^ a b c d e Guire, George Mc (2015). Handbook of Humanitarian Health Care Logistics: Designing the Supply Network and Managing the Flows of Information and Health Care Goods in Humanitarian Assistance during Complex Political Emergencies in low-resource settings. George Mc Guire. p. 668.
- ^ Anderson, Stuart; Huss, Reinhard; Summers, Rob; Wiedenmayer, Karin (2012). Managing Pharmaceuticals in International Health. Birkhäuser. p. 117. ISBN 978-3-0348-7913-2.
- ^ Lewis, R. F.; Dorlencourt, F.; Pinel, J. (1998). "Long-acting oily Chloramphenicol for Meningococcal Meningitis". Lancet. 352 (9130): 823. doi: 10.1016/S0140-6736(05)60723-4. PMID 9737323. S2CID 42224633.
 | This organization-related article is a stub. You can help Wikipedia by expanding it. |
The International Dispensary Association Foundation (IDA Foundation) was created in 1972 in Amsterdam. [1] Its goal is to improve access to important medications and health care equipment in the developing world. [1] It works to achieve this by directly selling these items to organizations working in those areas of the world. [1] It is a not for profit organisation. [2] As of 2019 they were selling more than 3,000 products in more than 130 countries. [1] What they distribute is based in part on the WHO Model List of Essential Medicines. [1]
Oily chloramphenicol (or chloramphenicol oil suspension) is a long-acting preparation of chloramphenicol first introduced by Roussel Uclaf in 1954; marketed as Tifomycine, it was originally used as a treatment for typhoid. Roussel stopped production of oily chloramphenicol in 1995; the IDA Foundation has manufactured it since 1998, first in Malta and then in India from December 2004. [3]
- ^ a b c d e Guire, George Mc (2015). Handbook of Humanitarian Health Care Logistics: Designing the Supply Network and Managing the Flows of Information and Health Care Goods in Humanitarian Assistance during Complex Political Emergencies in low-resource settings. George Mc Guire. p. 668.
- ^ Anderson, Stuart; Huss, Reinhard; Summers, Rob; Wiedenmayer, Karin (2012). Managing Pharmaceuticals in International Health. Birkhäuser. p. 117. ISBN 978-3-0348-7913-2.
- ^ Lewis, R. F.; Dorlencourt, F.; Pinel, J. (1998). "Long-acting oily Chloramphenicol for Meningococcal Meningitis". Lancet. 352 (9130): 823. doi: 10.1016/S0140-6736(05)60723-4. PMID 9737323. S2CID 42224633.
|
| This organization-related article is a stub. You can help Wikipedia by expanding it. |